Junfei Wei - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Junfei Wei

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Biorxiv : the Preprint Server for Biology|July 16, 2021

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concernJeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.

Expert Review of Vaccines|May 30, 2023

From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global accessPeter J Hotez, Rakesh Adhikari, Wen-Hsiang Chen, et al.

Science Immunology|July 16, 2021

A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primatesMaria Pino, Talha Abid, Susan Pereira Ribeiro, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Biorxiv : the Preprint Server for Biology|July 16, 2021

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concernJeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.

Expert Review of Vaccines|May 30, 2023

From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global accessPeter J Hotez, Rakesh Adhikari, Wen-Hsiang Chen, et al.

Science Immunology|July 16, 2021

A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primatesMaria Pino, Talha Abid, Susan Pereira Ribeiro, et al.

Pageof 4